157 related articles for article (PubMed ID: 17925610)
1. Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels.
Hoffmann R; Hamm C; Nienaber CA; Levenson B; Bonzel T; Sabin G; Senges J; Zahn R; Tebbe U; Pfannebecker T; Richardt HG; Schneider S; Kelm M;
Coron Artery Dis; 2007 Nov; 18(7):559-64. PubMed ID: 17925610
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions.
Price MJ; Sawhney N; Kao JA; Madrid A; Schatz RA; Teirstein PS
Catheter Cardiovasc Interv; 2005 Jun; 65(2):208-11. PubMed ID: 15880798
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
[TBL] [Abstract][Full Text] [Related]
6. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
7. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
[TBL] [Abstract][Full Text] [Related]
8. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
10. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
16. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term outcomes between everolimus-eluting and sirolimus-eluting stents in small vessels.
Kitabata H; Loh JP; Sardi GL; Badr S; Dvir D; Barbash IM; Pendyala LK; Minha S; Torguson R; Chen F; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2013 Apr; 111(7):973-8. PubMed ID: 23337837
[TBL] [Abstract][Full Text] [Related]
18. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
Bezerra H; Perin E; Berger P; Block P; Ramee S; Katz S; Kellet M; Dippel E; Schaer G; Britto S; Cohen S; Costa M
J Invasive Cardiol; 2010 Feb; 22(2):48-55. PubMed ID: 20124586
[TBL] [Abstract][Full Text] [Related]
20. Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduits.
Kitabata H; Loh JP; Pendyala LK; Badr S; Dvir D; Barbash IM; Minha S; Torguson R; Chen F; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2013 Jul; 112(1):61-7. PubMed ID: 23561590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
